Paper II
2024 December (Supplementary) (2019 Scheme) · 100 marks · 180 min
Question
Octreotide is a long acting synthetic analogue of:
- a) Growth hormone
- c) Somatostatin
- b) Prolactin
- d) Gonadotropin releasing hormone
Qii1 marksMCQs
Answer
Correct answer: c) Somatostatin
Octreotide is a long-acting synthetic analogue of somatostatin, with a much longer half-life than the native hormone (which is very rapidly degraded), used to suppress secretion of growth hormone (acromegaly), and various GI hormones (variceal bleeding, carcinoid syndrome, VIPomas).
Related Concepts
Other Years Asked
- 1Describe the uses, adverse effects and contraindications of atropine and atropine substitutes. (4+2+2)2022 February (2019 Scheme)Short Essay · 10 marks
- 2(2024 June (Supplementary) (2019 Scheme)Short Essay · 8 marks
- 3Mention four atropine substitutes with respective clinical indications for the same.2024 December (Supplementary) (2019 Scheme)Short Answer · 4 marks
- 4Compare and contrast: loperamide and racecadotril.2024 December (Supplementary) (2019 Scheme)Short Answer · 4 marks
- 5Assertion (A): Lactulose is used in hepatic encephalopathy. Reason (R): Lactulose is neither digested not absorbed in the small intestine, therefore retains water and produces soft formed stools by osmotic action.2024 December (Supplementary) (2019 Scheme)MCQ · 1 mark
- 6Prevention of constipation2013 April (2010 Scheme)Short Answer · 1 mark
- 7Which anti-diarrhoeal drug acts by inhibiting intestinal motility via opioid receptors2025 March (Supplementary (SAY)) (2019 Scheme)MCQ · 1 mark
- 8Super ORS2014 March (2010 Scheme)Short Answer · 1 mark
- 9Stimulant laxatives2018 February (2010 Scheme)Short Answer · 1 mark
- 10Lactulose in Hepatic encephalopathy2024 August (Supplementary) (2010 Scheme)Short Answer · 1 mark
- 11The drugs widely preferred to treat irritable bowel syndrome (IBS)2025 March (Supplementary (SAY)) (2019 Scheme)MCQ (Multi) · 1 mark
- 12The following is the right composition of oral rehydration solution as per WHO standard formula:2024 December (Supplementary) (2019 Scheme)MCQ · 1 mark
- 13Irritable bowel syndrome.2014 September (Supplementary) (2010 Scheme)Short Answer · 1 mark
- 14Laxatives2020 February (Supplementary) (2010 Scheme)Short Answer · 0.3 marks
- 15Drugs given for constipation2024 March (Supplementary) (2010 Scheme)Short Answer · 0.3 marks
- 16Antimotility drugs used in nonspecific diarrhoeas2022 May (Supplementary) (2010 Scheme)Short Answer · 0.3 marks
- 17Laxatives2023 March (Supplementary) (2010 Scheme)Short Answer · 0.3 marks
- 18Newer insulins2020 February (Supplementary) (2010 Scheme)Short Answer · 0.3 marks
- 19Anti-secretory agents in diarrhea2019 July (Supplementary) (2010 Scheme)Short Answer · 0.3 marks
- 20Stimulant purgatives2021 December (Supplementary) (2010 Scheme)Short Answer · 0.3 marks
- 21Drugs to treat Constipation2024 June (Supplementary) (2019 Scheme)Short Answer · 0.2 marks
- 22Laxative agents.2022 July (Supplementary) (2019 Scheme)Short Answer · 0.2 marks
- 23Antidiarrhoeal agents2023 January (Supplementary) (2019 Scheme)Short Answer · 0.2 marks
- 24Stimulant laxatives2024 March (Supplementary) (2019 Scheme)Short Answer · 0.2 marks

